Differential sequential patterns supporting insulin therapy of new-onset type 1 diabetes

被引:10
|
作者
Deja, Rafal [1 ]
Froelich, Wojciech [2 ]
Deja, Grazyna [3 ]
机构
[1] Acad Business Dabrowa Gornicza, Dept Comp Sci, Dabrowa Gornicza, Poland
[2] Univ Silesia, Inst Comp Sci, Sosnowiec, Poland
[3] Sch Med Katowice, Dept Pediat Pediat Endocrinol & Diabet, Katowice, Poland
来源
关键词
Data mining; Medical patterns; Diabetes mellitus; CHILDREN;
D O I
10.1186/s12938-015-0004-x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: In spite of numerous research efforts on supporting the therapy of diabetes mellitus, the subject still involves challenges and creates active interest among researchers. In this paper, a decision support tool is presented for setting insulin therapy in new-onset type 1 diabetes. Methods: The concept of differential sequential patterns (DSPs) is introduced with the aim of representing deviations in the patient's blood glucose level (BGL) and the amount of insulin injections administered. The decision support tool is created using data mining algorithms for discovering sequential patterns. Results: By using the DSPs, it is possible to support the physician's decisionmaking concerning changing the treatment (i.e., whether to increase or decrease the insulin dosage). The other contributions of the paper are an algorithm for generating DSPs and a new method for evaluating nocturnal glycaemia. The proposed qualitative evaluation of nocturnal glycaemia improves the generalization capabilities of the DSPs. Conclusions: The usefulness of the proposed approach was evident in the results of experiments in which juvenile diabetic patients actual data were used. It was confirmed that the proposed DSPs can be used to guide the therapy of numerous juvenile patients with type 1 diabetes.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] New-Onset Diabetes in Obese Adolescents - Type 1 or Type 2 Diabetes? Comparative Cases Report
    Gertig, Anna M.
    Niechcial, Elzbieta
    Skowronska, Bogda
    Fichna, Piotr
    JOURNAL OF DIABETES & METABOLISM, 2013, 4
  • [42] Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose
    Van Meter, SA
    Seaburg, H
    McLendon, B
    Doraiswamy, PM
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (12) : 993 - 994
  • [43] New-onset insulin-dependent diabetes due to nivolumab
    Zaied, Ali A.
    Akturk, Halis K.
    Joseph, Richard W.
    Lee, Augustine S.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2018,
  • [44] Statin Therapy Dose and Risk of New-Onset Diabetes
    McEvoy, John W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (12): : 1325 - 1326
  • [46] Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes
    Kaya, Aysem
    Onat, Altan
    Yuksel, Husniye
    Can, Gunay
    Yuksel, Murat
    Ademoglu, Evin
    POSTGRADUATE MEDICINE, 2017, 129 (06) : 611 - 618
  • [47] Statin therapy and new-onset diabetes: an attempt at recommendations
    Banach, Maciej
    Mikhailidis, Dimitri P.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (03) : 213 - 216
  • [48] Statin therapy and new-onset diabetes: A cause for concern?
    Preiss, David
    MATURITAS, 2012, 72 (02) : 95 - 96
  • [49] Antihypertensive therapy, new-onset diabetes, and cardiovascular disease
    Basile, J. N.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (04) : 656 - 666
  • [50] Diet and exercise for new-onset type 2 diabetes?
    Hu, Frank B.
    LANCET, 2011, 378 (9786): : 101 - 102